This process is guided by mechanical forces, which is why appropriate loading and weight-bearing during recovery matters so much
Specialist hepatologists may occasionally prescribe off-label in exceptional circumstances, particularly for patients with biopsy-proven NASH and significant fibrosis, but this is not routine practice
Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide.[1] That gap is not small, and for patients in Shreveport asking which medication is the better choice, this study provides the clearest evidence yet
Liraglutide for weight loss may be better known as its brand name, Saxenda
This increase is believed to be largely attributed to resolving GLP-1 drug shortages in 2024
This reduction in albuminuria was seen even in patients with moderate kidney impairment[7,51]